Login / Signup
Oral SERDs changing the scenery in hormone receptor positive breast cancer, a comprehensive review.
Mathilde Gheysen
Kevin Punie
Hans Wildiers
Patrick Neven
Published in:
Cancer treatment reviews (2024)
Oral SERDs constitute an exciting new drug class. Ongoing and future research will further refine the role of these drugs next to standard endocrine treatments and targeted therapies.
Keyphrases
</>
positive breast cancer
emergency department
drug induced